Search Results 691-700 of 18648 for hepatitis

  1. Isoniazid (oral route, intramuscular route) - Mayo Clinic

    Hepatitis may be especially likely to occur in patients over 50 years of age ... Liver disease—There may be an increased chance of hepatitis with daily drinking ...

  2. breast cancer survivors Archives - Mayo Clinic News Network

    ... hepatitis B or hepatitis C infection. Treatment depends on the size and location of the cancer, how well your liver is functioning and your overall health ...

  3. A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer - Mayo Clinic

    * Patients with positive serology for hepatitis B (unless immune due to ... * Active Hepatitis C virus (HCV) infection; patients who have completed ...

  4. Identify Exomic Alterations that Contribute to the Development of Liver Disease - Mayo Clinic

    ... hepatitis serologies; no history or suspicion of hypopituitarism (growth ... hepatitis serologies. Unexplained cholestatic liver disease. Definition ...

  5. Ofatumumab (intravenous route, subcutaneous route) - Mayo Clinic

    Hepatitis B, active—Should not be used in patients with this condition. Hepatitis B, or history of—Use with caution. May make this condition worse ...

  6. Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)™ - Mayo Clinic

    ACLF due to acute viral hepatitis A, B, B+D, C or E requiring antiviral treatment; 21. ACLF due to autoimmune hepatitis requiring high-dose steroid treatment;

  7. Mayo Clinic saved my life. Not once, but twice.

    For several months, the GI doctor thought he could reverse damage to my liver, which showed signs of hepatitis. But by September, I was in liver failure ...

  8. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    NOTE: Chronic stable hepatitis B and C (e.g., presence of hepatitis B surface antigen (HBsAg) or positive hepatitis C antibody test result at screening ...

  9. Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE) - Mayo Clinic

    - acute hepatitis A infection (presence of hepatitis A immunoglobulin M [IgM] at Screening) - positive hepatitis B surface antigen - positive hepatitis C ...

  10. Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV) - Mayo Clinic

    ... hepatitis B surface antigen [HBsAg]). Participants with resolved infection (example: participants who are HBsAg negative but positive for antibodies to ...